Our platform is built on decades of research by our founders, who are pioneers in Treg biology and cell therapy.
Platform & Pipeline
Restoring balance to the immune system has huge potential in the fight against autoimmune disease. These are our initial areas of focus.
![Dscf4395 Aspect Ratio 354 421](https://sonomabio.com/wp-content/uploads/2022/12/DSCF4395-aspect-ratio-354-421-861x1024.jpg)
![Dscf4446 Aspect Ratio 317 300](https://sonomabio.com/wp-content/uploads/2022/12/DSCF4446-aspect-ratio-317-300-1024x969.jpg)
Our Platform
![Dscf4543 Aspect Ratio 1558 1333](https://sonomabio.com/wp-content/uploads/2022/12/DSCF4543-aspect-ratio-1558-1333-1024x876.jpg)
Our Pipeline
We are applying our approach to combat specific disease states.
![Dscf4462 Crop Aspect Ratio 1569 1429](https://sonomabio.com/wp-content/uploads/2022/12/DSCF4462-crop-aspect-ratio-1569-1429-1024x933.jpg)
![Science Barker2 Aspect Ratio 611 614](https://sonomabio.com/wp-content/uploads/2023/02/science-barker2-aspect-ratio-611-614.jpg)
Our Science
We are developing therapies designed to impact both sides of the immune imbalance, with Treg cell therapeutics and a Teff modulating biologic.